SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-12-001781
Filing Date
2012-11-27
Accepted
2012-11-27 09:00:18
Documents
1
Period of Report
2012-11-26

Document Format Files

Seq Description Document Type Size
1 form4-11272012_091103.html 4  
1 form4-11272012_091103.xml 4 3092
  Complete submission text file 0001415889-12-001781.txt   4559
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Issuer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 500 BOYLSTON STREET, SUITE 1600 BOSTON MA 02116
Business Address
Spoor Johan M. (Reporting) CIK: 0001535289 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-147193 | Film No.: 121225519